Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator

[1] Mirowski M(1980)Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings N Engl J Med 303 322-324

[2] Reid PR(1997)A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1576-1583

[3] Mower MM(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 225-237

[4] Bardy GH(2000)Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 1297-1302

[5] Lee KL(2004)Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2151-2158

[6] Mark DB(2000)Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 748-754

[7] Connolly SJ(1996)Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1933-1940

[8] Gent M(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877-883

[9] Roberts RS(2012)ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 1787-1847

[10] Kadish A(2013)2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 e147-239

[1] Mirowski M(1980)Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings N Engl J Med 303 322-324

[2] Reid PR(1997)A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1576-1583

[3] Mower MM(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 225-237

[4] Bardy GH(2000)Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 1297-1302

[5] Lee KL(2004)Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2151-2158

[6] Mark DB(2000)Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 748-754

[7] Connolly SJ(1996)Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1933-1940

[8] Gent M(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877-883

[9] Roberts RS(2012)ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 1787-1847

[10] Kadish A(2013)2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 e147-239